Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pasquale Totaro, MD, Vincenzo Argano, MD 

Similar presentations


Presentation on theme: "Pasquale Totaro, MD, Vincenzo Argano, MD "— Presentation transcript:

1 Patient–prosthesis mismatch after mitral valve replacement: Myth or reality? 
Pasquale Totaro, MD, Vincenzo Argano, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 134, Issue 3, Pages (September 2007) DOI: /j.jtcvs Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 A, Comparison between preoperative predicted EOA and EOAI based on in vitro value published by the manufacturer and in vivo value measured postoperatively. B, Comparison between preoperative predicted EOA and EOAI in patients receiving size 25 and 27 prostheses. EOA, Effective orifice area; EOAI, indexed effective orifice area. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Comparison between preoperative predicted PPM based on in vitro value published by the manufacturer and in vivo PPM measured postoperatively (specificity 31%, sensitivity 6%). PPM, Patient–prosthesis mismatch. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Linear regression: No significant correlation is shown between increased size of bioprosthesis implanted and postoperative hemodynamic performance. Left, Postoperative pressure gradient. Right, Postoperative EOA. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions


Download ppt "Pasquale Totaro, MD, Vincenzo Argano, MD "

Similar presentations


Ads by Google